Jeffrey L. Wasserman is a Member of the Sills Cummis & Gross Corporate, Private Equity, Banking and Finance, and Life Sciences Practice Groups. He also leads the Firm’s Venture Capital/Regulated Substances Practice Group. Mr. Wasserman provides corporate counseling to private equity and venture capital funds, and public and private companies. His experience includes the structuring and negotiating of leveraged buy-outs, investments, complex acquisitions, secured and unsecured lending, and joint ventures/collaborations, in addition to general corporate advice.
Mr. Wasserman focuses on investment and regulatory issues in the legal medical and recreational cannabis-related marketplace. He has significant experience representing pharmaceutical and life sciences clients relating to acquisitions and divestitures, joint ventures and collaborations, product and technology licensing, and distribution arrangements. In addition, Mr. Wasserman’s experience includes licensing transactions in the entertainment industry, as well as physical and digital media distributors, and some of the largest “As Seen on TV” companies in the United States.
Prior to joining the Firm, Mr. Wasserman was most recently the Chief Executive Officer of a private-equity backed company in the over-the-counter consumer health industry. He also served in senior management positions for other prescription products and medical device corporations. He was a founding general partner and served as Senior Vice President and General Counsel to a Boca Raton, Florida-based private equity/venture capital fund. Mr. Wasserman started his career in the corporate and securities practice groups at Morgan Lewis and Mayer Brown & Platt in New York.
Mr. Wasserman has also served on a number of public and private boards of directors and regularly counsels boards on various matters.